A health worker preparing a COVID-19 vaccine. AFP/Anthony Wallace
JOHANNESBURG - The local partner for the Sinovac vaccine is assuring the public it's effective against the Delta variant of the coronavirus.
That's after a Lancet study found BioNTech vaccines such as Pfizer produce ten-times more antibodies.
The Numolux group says 2.5-million doses of Sinovac's COVID-19 vaccine can be made available if approved.
Additionally, the vaccine has a shelf-life of 24 months and can be stored in a normal refrigerator.